Felix Lee, MD
Interventional Cardiology · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 3 carriers
- Offices
- 14
Offices
14 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lee’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G83216 · Current
Licensed to practise in California · since 1996 · expires 2028-02-29 · University of Pennsylvania School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$576,492
Medicare paid this office $576,492 for 1,303 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 517 | $104,279 | $189 |
| Return visit (30+ min) | 589 | $100,749 | $109 |
| Long return visit (40+ min) | 369 | $91,540 | $164 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 146 | $69,190 | $471 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 157 | $66,994 | $106 |
See all 34 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 517 | $104,279 | $189 |
| Return visit (30+ min) | 589 | $100,749 | $109 |
| Long return visit (40+ min) | 369 | $91,540 | $164 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 146 | $69,190 | $471 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 157 | $66,994 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 137 | $23,754 | $152 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 194 | $12,635 | $61 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 24 | $11,287 | $72 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 135 | $9,659 | $65 |
| New patient visit (60+ min) | 47 | $8,480 | $180 |
| Transitional care management services for problem of high complexity | 30 | $7,823 | $261 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 26 | $6,127 | $236 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 70 | $5,043 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 71 | $4,673 | $21 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 145 | $4,202 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 266 | $4,094 | $13 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $4,061 | $60 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 138 | $3,685 | $14 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 21 | $3,363 | $160 |
| Ct scan of blood vessels and grafts of heart with contrast | 27 | $2,848 | $102 |
| Heart rhythm recording of continous external ekg over 8-15 days | 145 | $2,467 | $12 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $1,798 | $90 |
| External shock to heart to regulate heart beat | 12 | $1,365 | $98 |
| Programming of dual lead pacemaker system | 43 | $1,345 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 171 | $1,266 | $6 |
| Injection, regadenoson, 0.1 mg | 72 | $1,260 | None |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $813 | $68 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $668 | $26 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 19 | $506 | $27 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 43 | $473 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 16 | $305 | $18 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $293 | $15 |
| Ultrasonic guidance for blood vessel access | 21 | $251 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $47 | $3 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 16 | More than 41% of doctors who do this |
Who their Medicare patients are
1,303 Original Medicare patients in 2024. Average age 78 · Under 65 2% · 85 and older 24% · Women 53% · Also on Medicaid 10% · Health risk score 1.39. At or below the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 41% · Atrial fibrillation 37% · Heart failure 35% · Diabetes 34% · Chronic kidney disease 29% · Cancer 20% · Depression 18% · Stroke 16% · COPD 15% · Dementia 12%.
The office billed $2,592,620, Medicare allowed $766,808 and paid $576,492; for 5,984 services of 66 kinds; $1,617 of it was for drugs given in the office and $574,875 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,303 | 5,984 | 78 | 1.39 | $2,592,620 | $576,492 |
| 2023 | 1,313 | 5,399 | 78 | 1.33 | $2,075,067 | $518,257 |
| 2022 | 1,370 | 6,004 | 78 | 1.26 | $2,359,504 | $652,135 |
| 2021 | 1,379 | 6,267 | 78 | 1.29 | $2,360,318 | $644,199 |
| 2020 | 1,135 | 5,821 | 78 | 1.49 | $2,171,807 | $574,436 |
| 2019 | 1,211 | 5,672 | 78 | 1.41 | $2,251,786 | $557,461 |
| 2018 | 1,117 | 5,283 | 78 | 1.49 | $2,147,452 | $548,089 |
| 2017 | 1,102 | 5,175 | 77 | 1.46 | $1,968,430 | $514,327 |
| 2016 | 1,034 | 5,809 | 78 | 1.47 | $1,817,858 | $536,444 |
| 2015 | 1,033 | 7,611 | 78 | 1.48 | $1,329,793 | $550,249 |
| 2014 | 972 | 7,922 | 77 | 1.31 | $1,486,188 | $598,785 |
| 2013 | 930 | 7,757 | 77 | 1.35 | $1,386,153 | $542,067 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 34 services
| Long return visit (40+ min) | 482 | $118,311 | $161 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 481 | $100,743 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 146 | $69,365 | $110 |
| Return visit (30+ min) | 450 | $66,375 | $110 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 57 | $27,951 | $482 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 125 | $24,234 | $157 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 183 | $12,516 | $62 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 143 | $11,513 | $68 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 117 | $8,119 | $34 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 27 | $7,976 | $62 |
| New patient visit (60+ min) | 44 | $7,911 | $180 |
| Injection, regadenoson, 0.1 mg | 33 | $5,742 | None |
| Transitional care management services for problem of high complexity | 17 | $5,239 | $276 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 319 | $4,715 | $13 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 21 | $4,628 | $220 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 134 | $4,230 | $23 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $4,058 | $184 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 72 | $3,886 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 78 | $3,814 | $21 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 24 | $2,428 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 134 | $2,396 | $13 |
| Programming of dual lead pacemaker system | 47 | $1,723 | $31 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 20 | $1,545 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 152 | $1,193 | $7 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $1,175 | $98 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $1,135 | $21 |
| External shock to heart to regulate heart beat | 11 | $1,007 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $524 | $26 |
| Programming of dual lead pacemaker system | 11 | $486 | $35 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 20 | $433 | $20 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 31 | $341 | $11 |
| Ultrasonic guidance for blood vessel access | 18 | $225 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $197 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $31 | $3 |
2022: 31 services
| Return visit (30+ min) | 683 | $123,433 | $110 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 545 | $115,037 | $198 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 155 | $81,576 | $263 |
| Long return visit (40+ min) | 328 | $75,813 | $166 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 140 | $68,210 | $487 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $56,685 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 101 | $21,333 | $182 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 187 | $15,912 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 175 | $12,287 | $64 |
| New patient visit (60+ min) | 55 | $10,807 | $196 |
| Injection, regadenoson, 0.1 mg | 38 | $7,398 | None |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 84 | $4,989 | $25 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 90 | $4,852 | $23 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 21 | $4,693 | $223 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 146 | $4,497 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 271 | $4,101 | $13 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $4,012 | $182 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 33 | $3,071 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 146 | $2,858 | $15 |
| Programming of dual lead pacemaker system | 52 | $2,178 | $35 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,861 | $124 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 27 | $1,731 | $22 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,696 | $100 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 17 | $1,689 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 187 | $1,538 | $7 |
| External shock to heart to regulate heart beat | 11 | $1,329 | $102 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $562 | $27 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $446 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $333 | $17 |
| Ultrasonic guidance for blood vessel access | 15 | $187 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $49 | $3 |
2021: 35 services
| Return visit (30+ min) | 695 | $138,014 | $112 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 490 | $106,979 | $203 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 140 | $73,362 | $520 |
| Long return visit (40+ min) | 325 | $71,047 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 179 | $65,195 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 176 | $37,095 | $182 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 140 | $36,615 | $131 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 218 | $14,946 | $64 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 159 | $12,674 | $65 |
| Injection, regadenoson, 0.1 mg | 48 | $9,140 | None |
| New patient visit (60+ min) | 38 | $7,236 | $190 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 96 | $5,719 | $24 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $5,341 | $214 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 82 | $4,840 | $23 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 19 | $4,637 | $244 |
| Transitional care management services for problem of high complexity | 15 | $4,434 | $277 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 275 | $4,096 | $14 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 29 | $4,090 | $24 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 132 | $3,959 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 132 | $2,649 | $15 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $2,318 | $101 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 19 | $2,270 | $22 |
| Programming of dual lead pacemaker system | 50 | $1,784 | $31 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 15 | $1,678 | $23 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 23 | $1,664 | $72 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 145 | $1,198 | $8 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 17 | $947 | $33 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 55 | $652 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 29 | $610 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $557 | $28 |
| Programming of dual lead pacemaker system | 12 | $466 | $36 |
| Ultrasound of heart blood flow, valves and chambers | 27 | $456 | $17 |
| Ultrasonic guidance for blood vessel access | 21 | $265 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $150 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $62 | $3 |
2020: 35 services
| Return visit (30+ min) | 653 | $121,465 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 427 | $91,377 | $207 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 159 | $82,233 | $514 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 169 | $66,803 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 146 | $35,745 | $186 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 155 | $30,343 | $98 |
| Long return visit (40+ min) | 148 | $25,403 | $133 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 194 | $13,909 | $68 |
| Injection, regadenoson, 0.1 mg | 68 | $13,054 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 168 | $11,212 | $63 |
| New patient visit (60+ min) | 52 | $9,241 | $178 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $7,912 | $440 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 95 | $5,141 | $24 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $4,810 | $200 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 83 | $4,422 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 226 | $4,287 | $16 |
| Telephone medical discussion with physician, 21-30 minutes | 42 | $4,255 | $101 |
| External ekg recording for more than 48 hours up to 21 days | 124 | $4,043 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 123 | $3,558 | $23 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 27 | $3,531 | $24 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $2,710 | $246 |
| Ultrasound of heart with probe in esophagus, with report | 21 | $2,113 | $101 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 14 | $1,676 | $22 |
| External shock to heart to regulate heart beat | 13 | $1,672 | $104 |
| Programming of dual lead pacemaker system | 38 | $1,658 | $37 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 13 | $1,579 | $22 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 17 | $1,272 | $75 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $1,020 | $32 |
| Short return visit (20+ min) | 20 | $925 | $46 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 102 | $874 | $8 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 48 | $581 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $308 | $28 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $257 | $17 |
| Ultrasonic guidance for blood vessel access | 14 | $187 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $42 | $3 |
2019: 33 services
| Long return visit (40+ min) | 511 | $105,183 | $124 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 399 | $84,982 | $201 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 142 | $69,277 | $478 |
| Return visit (30+ min) | 477 | $62,914 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 183 | $59,414 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 146 | $30,509 | $184 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 151 | $29,305 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 172 | $12,633 | $68 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 148 | $9,919 | $64 |
| New patient visit (60+ min) | 50 | $9,139 | $183 |
| Injection, regadenoson, 0.1 mg | 43 | $7,894 | None |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $7,746 | $484 |
| Short return visit (20+ min) | 104 | $7,178 | $66 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 29 | $5,902 | $204 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 23 | $5,377 | $234 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 91 | $4,970 | $25 |
| External ekg recording for more than 48 hours up to 21 days | 121 | $4,292 | $27 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 78 | $4,233 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 201 | $4,124 | $16 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 121 | $3,783 | $24 |
| Ultrasound of heart with probe in esophagus, with report | 27 | $2,668 | $99 |
| Programming of dual lead pacemaker system | 45 | $2,165 | $33 |
| External shock to heart to regulate heart beat | 16 | $1,743 | $97 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 181 | $1,452 | $7 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 18 | $1,314 | $73 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $1,082 | $36 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 19 | $1,009 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 62 | $746 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 23 | $624 | $27 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $584 | $24 |
| Ultrasonic guidance for blood vessel access | 34 | $471 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $262 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $49 | $3 |
2018: 29 services
| Long return visit (40+ min) | 514 | $97,074 | $116 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 186 | $94,063 | $500 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 426 | $88,577 | $202 |
| Return visit (30+ min) | 498 | $65,227 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 152 | $44,688 | $93 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 185 | $35,214 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 121 | $23,835 | $181 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 195 | $12,292 | $62 |
| Injection, regadenoson, 0.1 mg | 64 | $11,348 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 144 | $9,774 | $66 |
| New patient visit (60+ min) | 42 | $7,536 | $179 |
| Short return visit (20+ min) | 90 | $6,153 | $65 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 75 | $4,544 | $26 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $4,423 | $211 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 18 | $3,983 | $221 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 60 | $3,510 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 174 | $3,499 | $16 |
| External ekg recording for more than 48 hours up to 21 days | 90 | $2,889 | $27 |
| Programming of dual lead pacemaker system | 54 | $2,555 | $32 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 90 | $2,512 | $24 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $2,075 | $99 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $1,558 | $46 |
| External shock to heart to regulate heart beat | 12 | $1,513 | $101 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 131 | $1,049 | $7 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 46 | $585 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $473 | $26 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $350 | $17 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $200 | $17 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 23 | $73 | $3 |
2017: 34 services
| Return visit (30+ min) | 621 | $97,436 | $84 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 367 | $87,748 | $219 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 152 | $76,286 | $486 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 186 | $60,442 | $90 |
| Long return visit (40+ min) | 326 | $52,908 | $123 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 133 | $26,378 | $176 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 152 | $23,844 | $92 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 157 | $10,901 | $64 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 36 | $9,515 | $264 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 138 | $7,938 | $56 |
| Injection, regadenoson, 0.1 mg | 40 | $7,115 | None |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,388 | $456 |
| New patient visit (60+ min) | 37 | $6,102 | $165 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 200 | $3,999 | $15 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $3,742 | $187 |
| Programming of dual lead pacemaker system | 53 | $3,512 | $31 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 44 | $2,608 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 35 | $2,211 | $28 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 24 | $2,161 | $83 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 18 | $1,873 | $26 |
| External shock to heart to regulate heart beat | 18 | $1,856 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 162 | $1,317 | $7 |
| External ekg recording for more than 48 hours up to 21 days | 41 | $1,271 | $28 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $1,151 | $46 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,149 | $96 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 41 | $1,102 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 36 | $937 | $26 |
| Programming of dual lead implantable defibrillator system | 11 | $709 | $47 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 38 | $412 | $11 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 17 | $387 | $23 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $292 | $19 |
| Ultrasonic guidance for blood vessel access | 23 | $286 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $178 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $31 | $3 |
2016: 30 services
| Return visit (30+ min) | 650 | $120,694 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 352 | $80,847 | $221 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 155 | $79,869 | $499 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 180 | $67,961 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 146 | $31,365 | $180 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 154 | $17,331 | $95 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 135 | $13,869 | $26 |
| Long return visit (40+ min) | 89 | $13,037 | $134 |
| Short return visit (20+ min) | 180 | $11,727 | $62 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 163 | $11,282 | $65 |
| Injection, regadenoson, 0.1 mg | 48 | $8,217 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 130 | $8,194 | $57 |
| New patient visit (60+ min) | 45 | $8,164 | $181 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 24 | $6,451 | $269 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 59 | $5,946 | $84 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $4,613 | $192 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 197 | $4,227 | $16 |
| Programming of dual lead pacemaker system | 54 | $3,622 | $36 |
| Programming of dual lead implantable defibrillator system | 23 | $1,731 | $52 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 65 | $1,553 | $13 |
| Blood test, clotting time | 85 | $1,538 | $5 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 14 | $1,120 | $59 |
| Short return visit | 37 | $1,040 | $28 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 13 | $924 | $71 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 20 | $820 | $27 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 97 | $774 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $614 | $26 |
| Ultrasonic guidance for blood vessel access | 14 | $179 | $13 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 14 | $174 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $144 | $13 |
2015: 28 services
| Return visit (30+ min) | 701 | $160,209 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 350 | $79,355 | $219 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 144 | $71,904 | $492 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 178 | $63,194 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 138 | $28,981 | $176 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 144 | $22,587 | $131 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 163 | $10,854 | $65 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 116 | $10,296 | $18 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 126 | $8,775 | $17 |
| Blood test, clotting time | 140 | $7,619 | $5 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 26 | $6,790 | $261 |
| Injection, regadenoson, 0.1 mg | 39 | $6,404 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 105 | $6,225 | $56 |
| New patient visit (45+ min) | 45 | $6,199 | $138 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 61 | $6,162 | $82 |
| Short return visit | 148 | $5,728 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 230 | $5,402 | $15 |
| Programming of dual lead pacemaker system | 59 | $5,273 | $53 |
| Ultrasound of both sides of head and neck blood flow | 22 | $4,391 | $200 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $2,923 | $195 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 135 | $1,171 | $8 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $716 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 27 | $694 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 13 | $651 | $27 |
| Blood test, lipids (cholesterol and triglycerides) | 13 | $224 | $17 |
| Injection, aminophyllin, up to 250 mg | 39 | $180 | None |
| Blood glucose (sugar) test performed by hand-held instrument | 14 | $44 | $3 |
| Infusion, normal saline solution, 250 cc | 44 | $13 | None |
2014: 34 services
| Return visit (30+ min) | 662 | $153,659 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 380 | $86,779 | $220 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 170 | $82,967 | $485 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 179 | $73,557 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 132 | $27,581 | $171 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 168 | $25,941 | $130 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 182 | $12,247 | $64 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 39 | $10,965 | $281 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 156 | $10,071 | $18 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 143 | $9,621 | $17 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 135 | $8,524 | $57 |
| Blood test, clotting time | 179 | $7,569 | $5 |
| New patient visit (45+ min) | 53 | $7,405 | $140 |
| Injection, regadenoson, 0.1 mg | 41 | $6,695 | None |
| Short return visit | 174 | $6,651 | $37 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,200 | $388 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 61 | $5,357 | $79 |
| Programming of dual lead pacemaker system | 58 | $5,219 | $50 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $5,182 | $192 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 239 | $4,917 | $15 |
| Ultrasound of both sides of head and neck blood flow | 22 | $4,321 | $196 |
| Ultrasound of leg arteries or artery grafts | 14 | $3,181 | $227 |
| Ultrasound of heart with probe in esophagus, with report | 30 | $2,848 | $92 |
| Ultrasound of leg arteries at rest and after exercise | 14 | $1,968 | $141 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 19 | $1,158 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 39 | $1,034 | $27 |
| Hospital discharge day management, 30 minutes or less | 14 | $917 | $65 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 12 | $672 | $24 |
| Blood test, lipids (cholesterol and triglycerides) | 28 | $539 | $17 |
| Ultrasound of heart blood flow, valves and chambers | 30 | $491 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 30 | $91 | $3 |
| Blood glucose (sugar) test performed by hand-held instrument | 25 | $79 | $3 |
| Injection, aminophyllin, up to 250 mg | 41 | $78 | None |
| Infusion, normal saline solution, 250 cc | 55 | $14 | None |
2013: 37 services
| Return visit (30+ min) | 618 | $137,961 | $91 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 150 | $79,943 | $506 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 174 | $69,650 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 372 | $68,256 | $177 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 137 | $25,379 | $170 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 150 | $22,695 | $130 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 164 | $11,801 | $66 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 193 | $11,065 | $18 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 135 | $9,596 | $17 |
| New patient visit (45+ min) | 47 | $6,640 | $141 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 101 | $6,594 | $55 |
| Blood test, clotting time | 176 | $6,568 | $5 |
| Injection, regadenoson, 0.1 mg | 35 | $6,286 | None |
| Short return visit | 150 | $6,018 | $38 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 25 | $6,009 | $231 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 62 | $5,618 | $80 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $5,332 | $197 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 213 | $5,012 | $17 |
| Ultrasound of both sides of head and neck blood flow | 27 | $4,867 | $180 |
| Programming of dual lead pacemaker system | 53 | $4,588 | $50 |
| Ultrasound of heart with probe in esophagus, with report | 30 | $2,981 | $90 |
| Ultrasound of leg arteries or artery grafts | 13 | $2,747 | $196 |
| Ultrasound of leg arteries at rest and after exercise | 13 | $2,050 | $146 |
| Blood test, lipids (cholesterol and triglycerides) | 90 | $1,787 | $13 |
| Hospital observation care on day of discharge | 17 | $1,139 | $63 |
| Short return visit (20+ min) | 15 | $893 | $60 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 12 | $823 | $69 |
| Programming of single lead pacemaker system | 11 | $793 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 70 | $629 | $7 |
| Ultrasound of heart blood flow, valves and chambers | 30 | $533 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $526 | $20 |
| Liver enzyme (sgpt), level | 73 | $464 | $6 |
| Liver enzyme (sgot), level | 73 | $460 | $6 |
| Blood glucose (sugar) test performed by hand-held instrument | 73 | $302 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 30 | $107 | $3 |
| Injection, aminophyllin, up to 250 mg | 35 | $27 | None |
| Infusion, normal saline solution, 250 cc | 50 | $12 | None |
Medicaid work
$1,378 in 2024
Medicaid paid $1,378 for 81 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 13 | $1,092 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 68 | $286 |
| 2024 | 81 | 2 | 25 | $1,378 |
| 2023 | 31 | 1 | 16 | $114 |
| 2022 | 50 | 1 | 16 | $250 |
| 2021 | 52 | 1 | 21 | $192 |
| 2020 | 30 | 1 | 16 | $141 |
| 2019 | 48 | 1 | 19 | $208 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 31 | $114 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 50 | $250 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 52 | $192 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 30 | $141 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 48 | $208 |
Drugs they prescribed that Part D paid
$1,126,154
Pharmacies billed $1,126,154 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 6,938) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
6,183 generic and 755 brand-name prescriptions · $1,126,154 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 454 | $700,958 | $1,544 |
| Repatha Sureclick | 68 | $67,653 | $995 |
| Entresto | 50 | $66,854 | $1,337 |
| Xarelto | 29 | $46,398 | $1,600 |
| Jardiance | 30 | $45,887 | $1,530 |
See all 49 drugs
| Eliquis | 454 | $700,958 | $1,544 |
| Repatha Sureclick | 68 | $67,653 | $995 |
| Entresto | 50 | $66,854 | $1,337 |
| Xarelto | 29 | $46,398 | $1,600 |
| Jardiance | 30 | $45,887 | $1,530 |
| Brilinta | 42 | $44,730 | $1,065 |
| Metoprolol | 1,265 | $21,563 | $17 |
| Atorvastatin | 864 | $9,132 | $11 |
| Losartan | 757 | $9,118 | $12 |
| Nifedipine Er | 200 | $8,173 | $41 |
| Rosuvastatin | 194 | $3,959 | $20 |
| Diltiazem 24hr Er (Cd) | 105 | $3,874 | $37 |
| Amlodipine Besylate | 396 | $3,160 | $8 |
| Potassium Chloride | 137 | $2,932 | $21 |
| Hydralazine | 96 | $1,891 | $20 |
| Ezetimibe | 54 | $1,831 | $34 |
| Clopidogrel | 98 | $1,830 | $19 |
| Carvedilol | 160 | $1,724 | $11 |
| Verapamil Er | 28 | $1,696 | $61 |
| Flecainide Acetate | 40 | $1,638 | $41 |
| Nebivolol | 14 | $1,637 | $117 |
| Furosemide | 255 | $1,608 | $6 |
| Propafenone | 30 | $1,558 | $52 |
| Lisinopril | 187 | $1,469 | $8 |
| Amiodarone | 52 | $1,446 | $28 |
| Fenofibrate | 25 | $1,368 | $55 |
| Simvastatin | 124 | $1,337 | $11 |
| Omega-3 Acid Ethyl Esters | 14 | $1,327 | $95 |
| Metoprolol | 149 | $1,230 | $8 |
| Bumetanide | 26 | $1,049 | $40 |
| Niacin Er | 15 | $937 | $62 |
| Hydrochlorothiazide | 194 | $929 | $5 |
| Triamterene-Hydrochlorothiazid | 67 | $919 | $14 |
| Sotalol | 31 | $818 | $26 |
| Warfarin | 43 | $738 | $17 |
| Atenolol | 92 | $696 | $8 |
| Isosorbide Mononitrate Er | 42 | $684 | $16 |
| Lovastatin | 29 | $608 | $21 |
| Digoxin | 25 | $539 | $22 |
| Olmesartan Medoxomil | 16 | $532 | $33 |
| Losartan-Hydrochlorothiazide | 24 | $514 | $21 |
| Pravastatin | 41 | $503 | $12 |
| Valsartan | 14 | $502 | $36 |
| Nitroglycerin | 19 | $466 | $25 |
| Diltiazem 24hr Er | 14 | $351 | $25 |
| Spironolactone | 25 | $270 | $11 |
| Benazepril | 29 | $247 | $9 |
| Ramipril | 13 | $197 | $15 |
| Clonidine | 17 | $188 | $11 |
Year by year
| 2024 | 6,938 | 741 | 0% (0) | 11% | $1,126,154 |
| 2023 | 7,282 | 744 | 0% (0) | 12% | $1,223,659 |
| 2022 | 7,599 | 745 | 0% (0) | 12% | $1,134,172 |
| 2021 | 7,344 | 731 | 0% (0) | 11% | $948,554 |
| 2020 | 7,122 | 669 | 0% (0) | 13% | $845,599 |
| 2019 | 6,590 | 638 | 0% (0) | 13% | $697,579 |
| 2018 | 5,449 | 586 | None | 14% | $493,922 |
| 2017 | 5,149 | 567 | 0% (0) | 15% | $342,777 |
| 2016 | 5,180 | 574 | None | 17% | $314,802 |
| 2015 | 5,182 | 545 | 0% (0) | None | $293,972 |
| 2014 | 5,142 | 540 | None | None | $290,478 |
| 2013 | 4,176 | 449 | 0% (0) | 20% | $238,319 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 53 drugs
| Eliquis | 519 | $765,420 | $1,475 |
| Jardiance | 38 | $63,436 | $1,669 |
| Repatha Sureclick | 48 | $60,391 | $1,258 |
| Entresto | 43 | $59,375 | $1,381 |
| Brilinta | 50 | $53,024 | $1,060 |
| Xarelto | 24 | $40,861 | $1,703 |
| Metoprolol | 1,259 | $25,413 | $20 |
| Repatha Pushtronex | 19 | $21,400 | $1,126 |
| Atorvastatin | 880 | $11,627 | $13 |
| Losartan | 730 | $10,309 | $14 |
| Nifedipine Er | 183 | $8,251 | $45 |
| Diltiazem 24hr Er (Cd) | 116 | $6,843 | $59 |
| Potassium Chloride | 143 | $4,480 | $31 |
| Propafenone | 52 | $4,139 | $80 |
| Amlodipine Besylate | 431 | $3,901 | $9 |
| Rosuvastatin | 190 | $3,862 | $20 |
| Amiodarone | 58 | $2,894 | $50 |
| Furosemide | 320 | $2,558 | $8 |
| Ezetimibe | 42 | $2,510 | $60 |
| Carvedilol | 170 | $2,504 | $15 |
| Clopidogrel | 119 | $2,099 | $18 |
| Lisinopril | 219 | $2,089 | $10 |
| Hydralazine | 110 | $1,868 | $17 |
| Verapamil Er | 27 | $1,653 | $61 |
| Bumetanide | 15 | $1,645 | $110 |
| Flecainide Acetate | 37 | $1,444 | $39 |
| Valsartan | 21 | $1,382 | $66 |
| Metoprolol | 151 | $1,335 | $9 |
| Simvastatin | 143 | $1,312 | $9 |
| Propranolol Hcl Er | 14 | $1,117 | $80 |
| Digoxin | 35 | $1,023 | $29 |
| Warfarin | 66 | $1,006 | $15 |
| Fenofibrate | 28 | $944 | $34 |
| Sotalol | 36 | $923 | $26 |
| Niacin Er | 14 | $878 | $63 |
| Triamterene-Hydrochlorothiazid | 64 | $799 | $12 |
| Klor-Con 10 | 20 | $797 | $40 |
| Olmesartan Medoxomil | 23 | $790 | $34 |
| Isosorbide Mononitrate Er | 46 | $775 | $17 |
| Atenolol | 96 | $768 | $8 |
| Hydrochlorothiazide | 219 | $742 | $3 |
| Diltiazem 24hr Er | 18 | $721 | $40 |
| Benazepril | 24 | $520 | $22 |
| Pravastatin | 38 | $498 | $13 |
| Losartan-Hydrochlorothiazide | 18 | $423 | $24 |
| Lovastatin | 30 | $361 | $12 |
| Nitroglycerin | 22 | $308 | $14 |
| Olmesartan-Hydrochlorothiazide | 12 | $295 | $25 |
| Ramipril | 22 | $286 | $13 |
| Clonidine | 19 | $251 | $13 |
| Spironolactone | 27 | $175 | $6 |
| Pantoprazole | 12 | $172 | $14 |
| Amoxicillin | 11 | $19 | $2 |
2022: 55 drugs
| Eliquis | 548 | $731,891 | $1,336 |
| Brilinta | 51 | $56,992 | $1,117 |
| Xarelto | 27 | $41,904 | $1,552 |
| Repatha Sureclick | 37 | $38,488 | $1,040 |
| Entresto | 24 | $33,996 | $1,417 |
| Jardiance | 18 | $29,195 | $1,622 |
| Metoprolol | 1,271 | $26,932 | $21 |
| Repatha Pushtronex | 21 | $22,214 | $1,058 |
| Atorvastatin | 893 | $11,414 | $13 |
| Nifedipine Er | 186 | $11,053 | $59 |
| Losartan | 763 | $10,092 | $13 |
| Diltiazem 24hr Er (Cd) | 117 | $6,942 | $59 |
| Rosuvastatin | 161 | $5,754 | $36 |
| Propafenone | 50 | $5,375 | $108 |
| Potassium Chloride | 159 | $5,263 | $33 |
| Ezetimibe | 41 | $4,679 | $114 |
| Amlodipine Besylate | 482 | $4,002 | $8 |
| Clopidogrel | 159 | $3,107 | $20 |
| Carvedilol | 192 | $3,104 | $16 |
| Amiodarone | 71 | $3,013 | $42 |
| Propranolol Hcl Er | 23 | $2,717 | $118 |
| Flecainide Acetate | 39 | $2,589 | $66 |
| Hydralazine | 107 | $2,500 | $23 |
| Verapamil Er | 31 | $1,982 | $64 |
| Lisinopril | 243 | $1,862 | $8 |
| Valsartan | 19 | $1,847 | $97 |
| Furosemide | 285 | $1,742 | $6 |
| Warfarin | 74 | $1,694 | $23 |
| Simvastatin | 193 | $1,641 | $9 |
| Bumetanide | 27 | $1,392 | $52 |
| Isosorbide Mononitrate Er | 57 | $1,346 | $24 |
| Olmesartan Medoxomil | 27 | $1,333 | $49 |
| Niacin Er | 14 | $1,274 | $91 |
| Fenofibrate | 22 | $1,213 | $55 |
| Sotalol | 43 | $1,128 | $26 |
| Metoprolol | 137 | $1,093 | $8 |
| Hydrochlorothiazide | 236 | $979 | $4 |
| Pravastatin | 47 | $972 | $21 |
| Triamterene-Hydrochlorothiazid | 62 | $944 | $15 |
| Nitroglycerin | 41 | $797 | $19 |
| Atenolol | 97 | $778 | $8 |
| Klor-Con 10 | 25 | $736 | $29 |
| Lovastatin | 28 | $678 | $24 |
| Digoxin | 31 | $635 | $20 |
| Klor-Con M20 | 12 | $545 | $45 |
| Benazepril | 34 | $518 | $15 |
| Olmesartan-Hydrochlorothiazide | 13 | $466 | $36 |
| Pantoprazole | 21 | $456 | $22 |
| Losartan-Hydrochlorothiazide | 24 | $323 | $13 |
| Clonidine | 23 | $316 | $14 |
| Spironolactone | 19 | $310 | $16 |
| Diltiazem | 12 | $289 | $24 |
| Jantoven | 16 | $247 | $15 |
| Ramipril | 19 | $233 | $12 |
| Labetalol | 11 | $118 | $11 |
2021: 51 drugs
| Eliquis | 485 | $608,336 | $1,254 |
| Brilinta | 55 | $63,548 | $1,155 |
| Repatha Sureclick | 41 | $31,231 | $762 |
| Metoprolol | 1,258 | $30,980 | $25 |
| Xarelto | 20 | $19,624 | $981 |
| Repatha Pushtronex | 27 | $18,488 | $685 |
| Atorvastatin | 843 | $14,653 | $17 |
| Losartan | 765 | $11,975 | $16 |
| Nifedipine Er | 174 | $11,804 | $68 |
| Diltiazem 24hr Er (Cd) | 118 | $7,746 | $66 |
| Rosuvastatin | 165 | $6,802 | $41 |
| Potassium Chloride | 153 | $5,614 | $37 |
| Propafenone | 46 | $5,253 | $114 |
| Flecainide Acetate | 53 | $4,543 | $86 |
| Propranolol Hcl Er | 24 | $4,077 | $170 |
| Amlodipine Besylate | 403 | $3,938 | $10 |
| Amiodarone | 70 | $3,588 | $51 |
| Clopidogrel | 138 | $3,062 | $22 |
| Carvedilol | 156 | $2,575 | $17 |
| Lisinopril | 270 | $2,513 | $9 |
| Ezetimibe | 41 | $2,340 | $57 |
| Hydralazine | 123 | $2,332 | $19 |
| Furosemide | 275 | $2,128 | $8 |
| Simvastatin | 200 | $2,026 | $10 |
| Verapamil Er | 41 | $1,912 | $47 |
| Warfarin | 65 | $1,631 | $25 |
| Pravastatin | 64 | $1,572 | $25 |
| Metoprolol | 144 | $1,534 | $11 |
| Bumetanide | 17 | $1,506 | $89 |
| Isosorbide Mononitrate Er | 42 | $1,446 | $34 |
| Olmesartan Medoxomil | 27 | $1,433 | $53 |
| Niacin Er | 20 | $1,409 | $70 |
| Hydrochlorothiazide | 300 | $1,307 | $4 |
| Atenolol | 86 | $1,174 | $14 |
| Digoxin | 25 | $1,073 | $43 |
| Fenofibrate | 23 | $1,003 | $44 |
| Valsartan | 16 | $906 | $57 |
| Triamterene-Hydrochlorothiazid | 61 | $903 | $15 |
| Fenofibrate | 15 | $664 | $44 |
| Lovastatin | 30 | $662 | $22 |
| Sotalol | 12 | $650 | $54 |
| Klor-Con 10 | 18 | $647 | $36 |
| Diltiazem | 18 | $623 | $35 |
| Nitroglycerin | 35 | $592 | $17 |
| Losartan-Hydrochlorothiazide | 19 | $525 | $28 |
| Pantoprazole | 18 | $509 | $28 |
| Irbesartan | 11 | $494 | $45 |
| Benazepril | 37 | $462 | $12 |
| Spironolactone | 20 | $389 | $19 |
| Ramipril | 20 | $243 | $12 |
| Clonidine | 11 | $200 | $18 |
2020: 55 drugs
| Eliquis | 461 | $498,650 | $1,082 |
| Brilinta | 56 | $53,161 | $949 |
| Xarelto | 38 | $37,855 | $996 |
| Metoprolol | 1,141 | $33,110 | $29 |
| Repatha Sureclick | 38 | $21,188 | $558 |
| Repatha Pushtronex | 31 | $16,943 | $547 |
| Atorvastatin | 810 | $15,620 | $19 |
| Losartan | 700 | $11,772 | $17 |
| Nifedipine Er | 158 | $9,894 | $63 |
| Rosuvastatin | 137 | $9,261 | $68 |
| Diltiazem 24hr Er (Cd) | 110 | $7,995 | $73 |
| Potassium Chloride | 152 | $6,817 | $45 |
| Flecainide Acetate | 43 | $5,954 | $138 |
| Propafenone | 58 | $5,332 | $92 |
| Amlodipine Besylate | 373 | $3,927 | $11 |
| Bystolic | 11 | $3,585 | $326 |
| Clopidogrel | 163 | $3,530 | $22 |
| Ezetimibe | 64 | $3,393 | $53 |
| Hydralazine | 104 | $3,023 | $29 |
| Amiodarone | 68 | $2,906 | $43 |
| Warfarin | 103 | $2,688 | $26 |
| Lisinopril | 250 | $2,521 | $10 |
| Simvastatin | 209 | $2,178 | $10 |
| Dilt-Xr | 17 | $2,091 | $123 |
| Carvedilol | 161 | $2,060 | $13 |
| Pravastatin | 64 | $1,915 | $30 |
| Niacin Er | 16 | $1,856 | $116 |
| Furosemide | 257 | $1,838 | $7 |
| Verapamil Er | 34 | $1,701 | $50 |
| Olmesartan Medoxomil | 18 | $1,676 | $93 |
| Hydrochlorothiazide | 345 | $1,675 | $5 |
| Toprol Xl | 12 | $1,613 | $134 |
| Metoprolol | 143 | $1,420 | $10 |
| Losartan-Hydrochlorothiazide | 24 | $1,359 | $57 |
| Atenolol | 79 | $1,347 | $17 |
| Valsartan | 15 | $1,258 | $84 |
| Isosorbide Mononitrate Er | 51 | $1,228 | $24 |
| Fenofibrate | 21 | $1,198 | $57 |
| Digoxin | 33 | $1,028 | $31 |
| Triamterene-Hydrochlorothiazid | 60 | $910 | $15 |
| Propranolol Hcl Er | 11 | $886 | $81 |
| Lovastatin | 32 | $835 | $26 |
| Sotalol | 14 | $646 | $46 |
| Nitroglycerin | 34 | $643 | $19 |
| Pantoprazole | 19 | $603 | $32 |
| Diltiazem | 18 | $562 | $31 |
| Ramipril | 20 | $558 | $28 |
| Irbesartan | 13 | $510 | $39 |
| Klor-Con 10 | 14 | $492 | $35 |
| Spironolactone | 19 | $481 | $25 |
| Benazepril | 44 | $402 | $9 |
| Fenofibrate | 11 | $346 | $31 |
| Cartia Xt | 12 | $272 | $23 |
| Lisinopril-Hydrochlorothiazide | 11 | $180 | $16 |
| Clonidine | 11 | $89 | $8 |
2019: 56 drugs
| Eliquis | 391 | $375,789 | $961 |
| Brilinta | 59 | $49,326 | $836 |
| Metoprolol | 958 | $35,169 | $37 |
| Xarelto | 49 | $33,290 | $679 |
| Repatha Sureclick | 38 | $25,446 | $670 |
| Repatha Pushtronex | 24 | $17,323 | $722 |
| Atorvastatin | 705 | $14,968 | $21 |
| Nifedipine Er | 142 | $10,329 | $73 |
| Rosuvastatin | 150 | $10,295 | $69 |
| Losartan | 629 | $8,677 | $14 |
| Potassium Chloride | 147 | $6,946 | $47 |
| Flecainide Acetate | 34 | $6,228 | $183 |
| Diltiazem 24hr Er (Cd) | 88 | $5,970 | $68 |
| Propafenone | 74 | $5,200 | $70 |
| Warfarin | 139 | $3,606 | $26 |
| Amlodipine Besylate | 315 | $3,542 | $11 |
| Niacin Er | 13 | $3,316 | $255 |
| Clopidogrel | 148 | $3,220 | $22 |
| Lisinopril | 298 | $2,988 | $10 |
| Ezetimibe | 36 | $2,945 | $82 |
| Hydralazine | 102 | $2,758 | $27 |
| Bystolic | 11 | $2,544 | $231 |
| Simvastatin | 198 | $2,539 | $13 |
| Amiodarone | 48 | $2,172 | $45 |
| Isosorbide Mononitrate Er | 55 | $2,018 | $37 |
| Pravastatin | 73 | $2,004 | $27 |
| Toprol Xl | 31 | $1,987 | $64 |
| Carvedilol | 149 | $1,852 | $12 |
| Hydrochlorothiazide | 334 | $1,809 | $5 |
| Fenofibrate | 28 | $1,800 | $64 |
| Furosemide | 221 | $1,614 | $7 |
| Metoprolol | 150 | $1,561 | $10 |
| Cartia Xt | 29 | $1,541 | $53 |
| Atenolol | 78 | $1,337 | $17 |
| Dilt-Xr | 18 | $1,293 | $72 |
| Olmesartan Medoxomil | 11 | $1,271 | $116 |
| Digoxin | 28 | $1,260 | $45 |
| Verapamil Sr | 11 | $1,038 | $94 |
| Valsartan | 17 | $1,031 | $61 |
| Verapamil Er | 25 | $937 | $37 |
| Lovastatin | 33 | $788 | $24 |
| Irbesartan | 13 | $777 | $60 |
| Klor-Con 10 | 12 | $749 | $62 |
| Triamterene-Hydrochlorothiazid | 59 | $703 | $12 |
| Fludrocortisone Acetate | 13 | $648 | $50 |
| Nitroglycerin | 37 | $637 | $17 |
| Pantoprazole | 15 | $505 | $34 |
| Olmesartan-Hydrochlorothiazide | 11 | $371 | $34 |
| Spironolactone | 18 | $362 | $20 |
| Benazepril | 31 | $327 | $11 |
| Ramipril | 19 | $320 | $17 |
| Losartan-Hydrochlorothiazide | 17 | $259 | $15 |
| Jantoven | 11 | $237 | $22 |
| Lisinopril-Hydrochlorothiazide | 12 | $183 | $15 |
| Clonidine | 16 | $146 | $9 |
| Amoxicillin | 14 | $26 | $2 |
2018: 50 drugs
| Eliquis | 273 | $238,839 | $875 |
| Metoprolol | 785 | $30,012 | $38 |
| Brilinta | 32 | $26,935 | $842 |
| Repatha Pushtronex | 21 | $25,469 | $1,213 |
| Repatha Sureclick | 17 | $21,861 | $1,286 |
| Xarelto | 20 | $12,440 | $622 |
| Atorvastatin | 568 | $11,966 | $21 |
| Ranexa | 16 | $10,496 | $656 |
| Rosuvastatin | 101 | $7,716 | $76 |
| Nifedipine Er | 114 | $6,792 | $60 |
| Niacin Er | 13 | $5,938 | $457 |
| Losartan | 437 | $5,335 | $12 |
| Potassium Chloride | 145 | $5,113 | $35 |
| Ezetimibe | 35 | $4,808 | $137 |
| Warfarin | 160 | $4,153 | $26 |
| Propafenone | 49 | $3,556 | $73 |
| Flecainide Acetate | 22 | $3,376 | $153 |
| Clopidogrel | 127 | $3,053 | $24 |
| Amlodipine Besylate | 272 | $2,816 | $10 |
| Lisinopril | 299 | $2,790 | $9 |
| Diltiazem 24hr Er (Cd) | 65 | $2,743 | $42 |
| Valsartan | 25 | $2,588 | $104 |
| Verapamil Sr | 23 | $2,433 | $106 |
| Hydralazine | 101 | $2,177 | $22 |
| Simvastatin | 164 | $1,927 | $12 |
| Toprol Xl | 33 | $1,895 | $57 |
| Digoxin | 29 | $1,640 | $57 |
| Furosemide | 232 | $1,627 | $7 |
| Pravastatin | 49 | $1,580 | $32 |
| Isosorbide Mononitrate Er | 44 | $1,477 | $34 |
| Metoprolol | 138 | $1,463 | $11 |
| Cartia Xt | 50 | $1,446 | $29 |
| Carvedilol | 127 | $1,425 | $11 |
| Hydrochlorothiazide | 254 | $1,394 | $5 |
| Fenofibrate | 19 | $1,361 | $72 |
| Amiodarone | 55 | $1,326 | $24 |
| Olmesartan Medoxomil | 14 | $1,065 | $76 |
| Triamterene-Hydrochlorothiazid | 61 | $895 | $15 |
| Atenolol | 62 | $822 | $13 |
| Digox | 11 | $686 | $62 |
| Verapamil Er | 17 | $616 | $36 |
| Irbesartan | 14 | $609 | $43 |
| Lovastatin | 21 | $522 | $25 |
| Sotalol | 20 | $373 | $19 |
| Ramipril | 13 | $335 | $26 |
| Nitroglycerin | 15 | $295 | $20 |
| Jantoven | 12 | $273 | $23 |
| Benazepril | 27 | $273 | $10 |
| Spironolactone | 15 | $273 | $18 |
| Losartan-Hydrochlorothiazide | 20 | $145 | $7 |
2017: 49 drugs
| Eliquis | 145 | $126,394 | $872 |
| Metoprolol | 705 | $27,891 | $40 |
| Brilinta | 33 | $22,777 | $690 |
| Xarelto | 25 | $16,377 | $655 |
| Atorvastatin | 544 | $11,470 | $21 |
| Zetia | 17 | $9,520 | $560 |
| Rosuvastatin | 74 | $7,080 | $96 |
| Potassium Chloride | 145 | $5,748 | $40 |
| Warfarin | 192 | $5,539 | $29 |
| Nifedipine Er | 88 | $4,989 | $57 |
| Losartan | 400 | $4,787 | $12 |
| Ezetimibe | 16 | $4,185 | $262 |
| Valsartan | 30 | $4,111 | $137 |
| Clopidogrel | 147 | $3,660 | $25 |
| Coreg Cr | 12 | $3,307 | $276 |
| Diltiazem 24hr Er | 59 | $3,129 | $53 |
| Flecainide Acetate | 23 | $2,948 | $128 |
| Propafenone | 35 | $2,900 | $83 |
| Amlodipine Besylate | 254 | $2,591 | $10 |
| Lisinopril | 296 | $2,423 | $8 |
| Niacin Er | 11 | $2,390 | $217 |
| Simvastatin | 185 | $2,316 | $13 |
| Verapamil Sr | 18 | $2,211 | $123 |
| Digoxin | 31 | $2,003 | $65 |
| Amiodarone | 64 | $1,771 | $28 |
| Hydralazine | 79 | $1,690 | $21 |
| Furosemide | 212 | $1,690 | $8 |
| Cartia Xt | 52 | $1,614 | $31 |
| Metoprolol | 148 | $1,611 | $11 |
| Hydrochlorothiazide | 264 | $1,600 | $6 |
| Pravastatin | 45 | $1,570 | $35 |
| Toprol Xl | 29 | $1,550 | $53 |
| Olmesartan-Hydrochlorothiazide | 11 | $1,443 | $131 |
| Carvedilol | 134 | $1,405 | $10 |
| Fenofibrate | 19 | $1,245 | $66 |
| Triamterene-Hydrochlorothiazid | 67 | $1,129 | $17 |
| Isosorbide Mononitrate Er | 42 | $1,041 | $25 |
| Verapamil Er | 15 | $815 | $54 |
| Atenolol | 91 | $696 | $8 |
| Lovastatin | 24 | $646 | $27 |
| Klor-Con Sprinkle | 16 | $567 | $35 |
| Jantoven | 12 | $367 | $31 |
| Ramipril | 16 | $344 | $22 |
| Irbesartan | 11 | $335 | $30 |
| Benazepril | 28 | $303 | $11 |
| Nitroglycerin | 17 | $276 | $16 |
| Sotalol | 12 | $262 | $22 |
| Spironolactone | 11 | $173 | $16 |
| Losartan-Hydrochlorothiazide | 14 | $115 | $8 |
2016: 50 drugs
| Eliquis | 114 | $82,769 | $726 |
| Crestor | 57 | $30,058 | $527 |
| Metoprolol | 756 | $29,099 | $38 |
| Zetia | 39 | $21,647 | $555 |
| Atorvastatin | 551 | $15,051 | $27 |
| Xarelto | 16 | $9,712 | $607 |
| Potassium Chloride | 163 | $7,305 | $45 |
| Pradaxa | 11 | $6,656 | $605 |
| Warfarin | 270 | $6,448 | $24 |
| Clopidogrel | 193 | $4,928 | $26 |
| Losartan | 369 | $4,551 | $12 |
| Valsartan | 27 | $4,508 | $167 |
| Nifedipine Er | 87 | $4,339 | $50 |
| Niacin Er | 17 | $3,807 | $224 |
| Diltiazem 24hr Er | 45 | $3,779 | $84 |
| Lisinopril | 264 | $2,539 | $10 |
| Amlodipine Besylate | 189 | $2,463 | $13 |
| Rosuvastatin | 24 | $2,431 | $101 |
| Simvastatin | 200 | $2,384 | $12 |
| Fenofibrate | 18 | $2,371 | $132 |
| Propafenone | 52 | $2,112 | $41 |
| Amiodarone | 47 | $1,946 | $41 |
| Metoprolol | 160 | $1,817 | $11 |
| Verapamil Er | 28 | $1,782 | $64 |
| Furosemide | 237 | $1,774 | $7 |
| Toprol Xl | 30 | $1,770 | $59 |
| Digoxin | 24 | $1,765 | $74 |
| Pravastatin | 40 | $1,628 | $41 |
| Hydrochlorothiazide | 266 | $1,602 | $6 |
| Cartia Xt | 31 | $1,393 | $45 |
| Carvedilol | 103 | $1,294 | $13 |
| Flecainide Acetate | 25 | $1,211 | $48 |
| Hydralazine | 45 | $1,160 | $26 |
| Triamterene-Hydrochlorothiazid | 55 | $1,068 | $19 |
| Klor-Con 10 | 15 | $979 | $65 |
| Isosorbide Mononitrate Er | 34 | $954 | $28 |
| Atenolol | 111 | $882 | $8 |
| Valsartan-Hydrochlorothiazide | 20 | $725 | $36 |
| Lovastatin | 26 | $678 | $26 |
| Nifedical Xl | 25 | $673 | $27 |
| Nitrostat | 24 | $625 | $26 |
| Bumetanide | 12 | $606 | $50 |
| Ramipril | 12 | $494 | $41 |
| Jantoven | 14 | $337 | $24 |
| Benazepril | 27 | $311 | $12 |
| Irbesartan | 12 | $297 | $25 |
| Losartan-Hydrochlorothiazide | 15 | $282 | $19 |
| Sotalol | 12 | $200 | $17 |
| Quinapril | 11 | $181 | $16 |
| Clonidine | 11 | $100 | $9 |
2015: 59 drugs
| Eliquis | 79 | $43,201 | $547 |
| Crestor | 74 | $35,689 | $482 |
| Metoprolol | 685 | $30,240 | $44 |
| Zetia | 40 | $15,604 | $390 |
| Atorvastatin | 533 | $14,484 | $27 |
| Warfarin | 325 | $8,755 | $27 |
| Potassium Chloride | 175 | $8,011 | $46 |
| Xarelto | 20 | $7,717 | $386 |
| Benicar | 15 | $7,589 | $506 |
| Niacin Er | 22 | $7,428 | $338 |
| Nifedipine Er | 93 | $6,817 | $73 |
| Enoxaparin | 24 | $6,476 | $270 |
| Vytorin | 16 | $5,727 | $358 |
| Clopidogrel | 224 | $5,389 | $24 |
| Fenofibrate | 23 | $4,817 | $209 |
| Valsartan | 23 | $3,947 | $172 |
| Propafenone | 63 | $3,765 | $60 |
| Losartan | 281 | $3,393 | $12 |
| Toprol Xl | 33 | $3,047 | $92 |
| Pravastatin | 45 | $2,338 | $52 |
| Fenofibrate | 20 | $2,333 | $117 |
| Lisinopril | 272 | $2,250 | $8 |
| Simvastatin | 199 | $2,192 | $11 |
| Midodrine | 20 | $2,104 | $105 |
| Diltiazem 24hr Er | 41 | $1,961 | $48 |
| Furosemide | 257 | $1,769 | $7 |
| Hydrochlorothiazide | 268 | $1,652 | $6 |
| Flecainide Acetate | 21 | $1,546 | $74 |
| Metoprolol | 168 | $1,516 | $9 |
| Diltiazem 24hr Cd | 14 | $1,441 | $103 |
| Amlodipine Besylate | 137 | $1,435 | $10 |
| Nifedical Xl | 32 | $1,418 | $44 |
| Amiodarone | 55 | $1,414 | $26 |
| Digoxin | 15 | $1,367 | $91 |
| Klor-Con 10 | 17 | $1,208 | $71 |
| Carvedilol | 93 | $1,125 | $12 |
| Triamterene-Hydrochlorothiazid | 62 | $1,122 | $18 |
| Atenolol | 122 | $1,040 | $9 |
| Isosorbide Mononitrate Er | 32 | $970 | $30 |
| Valsartan-Hydrochlorothiazide | 24 | $952 | $40 |
| Doxazosin Mesylate | 20 | $812 | $41 |
| Nitrostat | 38 | $783 | $21 |
| Diltiazem Er | 15 | $737 | $49 |
| Cartia Xt | 16 | $734 | $46 |
| Bumetanide | 13 | $715 | $55 |
| Hydralazine | 37 | $711 | $19 |
| Fludrocortisone Acetate | 11 | $705 | $64 |
| Verapamil Sr | 15 | $659 | $44 |
| Verapamil Er | 20 | $617 | $31 |
| Lovastatin | 32 | $566 | $18 |
| Klor-Con M20 | 13 | $498 | $38 |
| Irbesartan | 12 | $459 | $38 |
| Benazepril | 25 | $451 | $18 |
| Digox | 12 | $428 | $36 |
| Diltiazem | 12 | $404 | $34 |
| Ramipril | 12 | $371 | $31 |
| Losartan-Hydrochlorothiazide | 23 | $352 | $15 |
| Clonidine | 23 | $216 | $9 |
| Sotalol | 11 | $147 | $13 |
2014: 58 drugs
| Metoprolol | 713 | $34,936 | $49 |
| Crestor | 68 | $29,183 | $429 |
| Atorvastatin | 476 | $15,341 | $32 |
| Zetia | 39 | $13,410 | $344 |
| Eliquis | 26 | $12,863 | $495 |
| Enoxaparin | 33 | $11,615 | $352 |
| Vytorin | 30 | $11,098 | $370 |
| Diovan | 20 | $9,488 | $474 |
| Warfarin | 304 | $7,370 | $24 |
| Clopidogrel | 198 | $7,305 | $37 |
| Nifedipine Er | 103 | $7,115 | $69 |
| Potassium Chloride | 144 | $6,622 | $46 |
| Niacin Er | 12 | $4,639 | $387 |
| Effient | 14 | $4,622 | $330 |
| Fenofibrate | 21 | $4,383 | $209 |
| Losartan | 216 | $3,560 | $16 |
| Propafenone | 48 | $3,547 | $74 |
| Simvastatin | 246 | $3,130 | $13 |
| Pravastatin | 63 | $2,935 | $47 |
| Lisinopril | 309 | $2,853 | $9 |
| Fenofibrate | 21 | $2,536 | $121 |
| Nifedical Xl | 46 | $2,414 | $52 |
| Diltiazem 24hr Er | 42 | $2,281 | $54 |
| Metoprolol | 184 | $1,826 | $10 |
| Hydrochlorothiazide | 290 | $1,781 | $6 |
| Toprol Xl | 27 | $1,752 | $65 |
| Amlodipine Besylate | 159 | $1,741 | $11 |
| Digox | 33 | $1,722 | $52 |
| Flecainide Acetate | 24 | $1,716 | $71 |
| Valsartan-Hydrochlorothiazide | 23 | $1,716 | $75 |
| Klor-Con 10 | 26 | $1,595 | $61 |
| Amiodarone | 55 | $1,516 | $28 |
| Furosemide | 212 | $1,368 | $6 |
| Cartia Xt | 18 | $1,275 | $71 |
| Isosorbide Mononitrate Er | 34 | $1,254 | $37 |
| Diltiazem Er | 34 | $1,221 | $36 |
| Atenolol | 120 | $1,208 | $10 |
| Carvedilol | 85 | $1,195 | $14 |
| Klor-Con M20 | 28 | $1,136 | $41 |
| Hydralazine | 30 | $1,116 | $37 |
| Triamterene-Hydrochlorothiazid | 68 | $1,049 | $15 |
| Midodrine | 11 | $1,019 | $93 |
| Digoxin | 12 | $972 | $81 |
| Fludrocortisone Acetate | 13 | $901 | $69 |
| Diltiazem 24hr Cd | 17 | $872 | $51 |
| Bumetanide | 18 | $818 | $45 |
| Irbesartan | 11 | $757 | $69 |
| Verapamil Sr | 14 | $753 | $54 |
| Lovastatin | 28 | $562 | $20 |
| Nitrostat | 36 | $518 | $14 |
| Doxazosin Mesylate | 14 | $501 | $36 |
| Verapamil Er | 12 | $457 | $38 |
| Ramipril | 11 | $456 | $41 |
| Benazepril | 27 | $452 | $17 |
| Sotalol | 16 | $429 | $27 |
| Losartan-Hydrochlorothiazide | 19 | $428 | $23 |
| Clonidine | 19 | $226 | $12 |
| Spironolactone | 12 | $180 | $15 |
2013: 50 drugs
| Metoprolol | 534 | $29,513 | $55 |
| Crestor | 50 | $19,686 | $394 |
| Atorvastatin | 367 | $19,434 | $53 |
| Clopidogrel | 180 | $14,727 | $82 |
| Lipitor | 17 | $7,690 | $452 |
| Nifedipine Er | 101 | $7,671 | $76 |
| Zetia | 22 | $7,339 | $334 |
| Enoxaparin | 16 | $7,205 | $450 |
| Propafenone | 45 | $7,011 | $156 |
| Diovan | 16 | $6,584 | $411 |
| Warfarin | 230 | $5,754 | $25 |
| Potassium Chloride | 116 | $5,431 | $47 |
| Fenofibrate | 15 | $5,225 | $348 |
| Vytorin | 11 | $4,481 | $407 |
| Losartan | 179 | $4,240 | $24 |
| Benicar | 11 | $4,237 | $385 |
| Simvastatin | 240 | $3,642 | $15 |
| Nifedical Xl | 45 | $3,261 | $72 |
| Lisinopril | 239 | $2,404 | $10 |
| Diltiazem 24hr Er | 43 | $2,379 | $55 |
| Diovan Hct | 12 | $2,333 | $194 |
| Toprol Xl | 28 | $2,130 | $76 |
| Fenofibrate | 15 | $2,048 | $137 |
| Diltiazem 24hr Cd | 28 | $1,888 | $67 |
| Hydralazine | 35 | $1,793 | $51 |
| Metoprolol | 145 | $1,723 | $12 |
| Amlodipine Besylate | 124 | $1,681 | $14 |
| Carvedilol | 73 | $1,558 | $21 |
| Furosemide | 210 | $1,492 | $7 |
| Amiodarone | 45 | $1,437 | $32 |
| Hydrochlorothiazide | 251 | $1,348 | $5 |
| Atenolol | 119 | $1,325 | $11 |
| Flecainide Acetate | 16 | $1,264 | $79 |
| Klor-Con 10 | 21 | $1,216 | $58 |
| Pravastatin | 45 | $1,132 | $25 |
| Triamterene-Hctz | 60 | $984 | $16 |
| Fludrocortisone Acetate | 16 | $838 | $52 |
| Diltiazem Er | 11 | $792 | $72 |
| Klor-Con M20 | 20 | $773 | $39 |
| Isosorbide Mononitrate Er | 23 | $704 | $31 |
| Lovastatin | 20 | $608 | $30 |
| Ramipril | 18 | $605 | $34 |
| Losartan-Hydrochlorothiazide | 26 | $471 | $18 |
| Metolazone | 11 | $407 | $37 |
| Nitrostat | 23 | $371 | $16 |
| Benazepril | 16 | $352 | $22 |
| Bumetanide | 11 | $323 | $29 |
| Digox | 24 | $303 | $13 |
| Spironolactone | 11 | $268 | $24 |
| Enalapril Maleate | 12 | $165 | $14 |
Money from drug and device companies
$1,758 in 2025
| 2025 | 4 | 21 | None | $1,758 |
| 2024 | 6 | 7 | None | $693 |
| 2023 | 4 | 4 | None | $458 |
| 2022 | 5 | 8 | None | $1,555 |
| 2021 | 8 | 13 | None | $893 |
| 2020 | 6 | 15 | None | $1,136 |
| 2019 | 11 | 67 | None | $4,933 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Symplicity G3 | $1,136 | 17 payments
|
| CVRx | Barostim Neo System | $261 | 1 payment
|
| Boston Scientific | General - Therapies | $206 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $156 | 2 payments
|
See all 21 published payments
| Medtronic | Meals · 2025-12-08 | Symplicity G3 | $3 |
| Medtronic | Meals · 2025-09-13 | Symplicity G3 | $65 |
| Medtronic | Meals · 2025-09-13 | Symplicity G3 | $20 |
| Medtronic | Meals · 2025-09-13 | Symplicity G3 | $85 |
| Medtronic | Meals · 2025-09-13 | Symplicity G3 | $20 |
| Medtronic | Travel · 2025-09-12 | Symplicity G3 | $184 |
| Medtronic | Travel · 2025-09-12 | Symplicity G3 | $30 |
| Medtronic | Meals · 2025-09-12 | Symplicity G3 | $135 |
| Medtronic | Travel · 2025-09-12 | Symplicity G3 | $93 |
| Medtronic | Travel · 2025-08-09 | Symplicity G3 | $5 |
| Medtronic | Travel · 2025-08-09 | Symplicity G3 | $5 |
| Medtronic | Travel · 2025-08-08 | Symplicity G3 | $239 |
| Medtronic | Travel · 2025-08-08 | Symplicity G3 | $92 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-06-16 | Lifevest | $136 |
| Boston Scientific | Meals · 2025-03-30 | General - Therapies | $206 |
| Medtronic | Meals · 2025-03-29 | Corevalve Evolut R | $64 |
| CVRx | Meals · 2025-03-29 | Barostim Neo System | $261 |
| Medtronic | Meals · 2025-03-06 | Corevalve Evolut R | $64 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-01-21 | Lifevest | $20 |
| Medtronic | Meals · 2025-01-13 | Ffrangio | $18 |
| Medtronic | Meals · 2025-01-06 | Ffrangio | $14 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $693
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $199 | 1 payment
|
| Medtronic | Corevalve Evolut R | $179 | 2 payments
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $143 | 1 payment
|
| Amgen | Repatha | $125 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $26 | 1 payment
|
| Penumbra | Indigo System | $22 | 1 payment
|
2023: $458
| GE HealthCare | None | $156 | 1 payment
|
| HeartFlow | Ffrct | $143 | 1 payment
|
| Asahi Intecc USA | Asahi Ptca Guide Wire | $138 | 1 payment
|
| Medtronic | Corevalve Evolut R | $20 | 1 payment
|
2022: $1,555
| Intuitive Surgical | Davinci Xi | $1,029 | 2 payments
|
| Biotronik | Rivacor 7 Dr-T | $356 | 3 payments
|
| HeartFlow | Ffrct | $132 | 1 payment
|
| Abbott Laboratories | Confirm Rx | $21 | 1 payment
|
| AngioDynamics | Angiovac | $18 | 1 payment
|
2021: $893
| Biotronik | Orsiro | $451 | 4 payments
|
| Penumbra | Indigo System | $140 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $99 | 1 payment
|
| Medtronic | Linq II | $86 | 2 payments
|
| Abbott Laboratories | Mitraclip System | $38 | 2 payments
|
| AngioDynamics | Angiovac | $29 | 1 payment
|
| Philips Electronics North America | (8333) Igt D Coronary | $28 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $21 | 1 payment
|
2020: $1,136
| Biotronik | None | $652 | 7 payments
|
| Medtronic Vascular | Micra | $296 | 2 payments
|
| Boston Scientific | General - Structural Heart | $91 | 1 payment
|
| Abbott Laboratories | Quadra Assura Crt Defibrillator | $42 | 2 payments
|
| Philips Electronics North America | Igt D Coronary | $40 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $14 | 1 payment
|
2019: $4,933
| Biotronik | None | $2,079 | 23 payments
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $1,420 | 9 payments
|
| Medtronic Vascular | Micra | $519 | 4 payments
|
| Abbott Laboratories | Cardiomems Hf System | $347 | 4 payments
|
| Philips Electronics North America | Igt D Coronary | $287 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $127 | 18 payments
|
| Boston Scientific | General Brady | $53 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $38 | 1 payment
|
| Amgen | None | $24 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $19 | 1 payment
|
| Acist Medical Systems | Hd-Ivus | $19 | 1 payment
|
Professional record
- NPI
- 1811975113
- Licence
- CA G83216California G83216: Current · expires 2028-02-29
- Trained
- Perelman School of Med at the University of Pennsylvania, 1995
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir Fl 2, Los Altos, CA, 94022
- NPI first listed
- 2006-01-06
- NPI last updated
- 2023-03-22
- NPI record certified
- 2023-03-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2581 Samaritan Dr, San Jose, CA, 95124